Contact: Michael Willett Investor and Public Relations Officer Bruker Daltonics Tel. 978-663-3660, ext. 1411 Email: ir@bruker-biosciences.com Kate Corcoran, Ph.D. Vice President, Corporate Development Isis PharmaceuticalsManufacturing and Distribution Agreement • July 31st, 2006 • Isis Pharmaceuticals Inc • Pharmaceutical preparations
